Your session is about to expire
← Back to Search
Cash Transfers for Premature Birth
N/A
Waitlist Available
Led By Andrea Duncan, MD
Research Sponsored by Children's Hospital of Philadelphia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
Study Summary
This trial will study whether giving cash to birthing parents of preterm babies in a NICU in PA can help reduce stress and help parents invest in their baby's care.
Who is the study for?
This trial is for Medicaid-insured or uninsured parents who meet income requirements, are over 18, speak English or Spanish fluently, live in Philadelphia county, and have a preterm infant born between 22 and less than 36 weeks gestational age. It's not for those likely to move out of state within a year or planning to put their infant up for adoption.Check my eligibility
What is being tested?
The study tests whether giving cash with no strings attached (either a high-value or low-value amount) can help parents of preterm babies by reducing stress and improving the ability to care for their infants. This pilot study will take place in one NICU in Pennsylvania.See study design
What are the potential side effects?
Since this trial involves financial support rather than medical treatment, there aren't traditional side effects. However, the impact on parental stress levels and investment in infant care will be closely monitored.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Acceptability of randomizing high-value and low-value unconditional cash transfers (UCT) to low income birthing parents of preterm infants.
Feasibility of enrolling caregivers of preterm infants in the study procedures and receipt of UCTs.
Secondary outcome measures
Lived experiences of caring for a preterm infant admitted to the neonatal intensive care unit.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: High-Value Cash TransferExperimental Treatment1 Intervention
Participants in the treatment group will receive four $325 payments. The first payment will be disbursed at the time of enrollment (between birth and 4 weeks of age), and second payment on the infant's one-month birthday, third payment on the infant's two-month birthday, and the fourth payment on the infant's three-month birthdays.
Group II: Low-Value Cash TransferActive Control1 Intervention
Participants in the control group will receive four $25 payments. The first payment will be disbursed at the time of enrollment (between birth and 4 weeks of age), and second payment on the infant's one-month birthday, third payment on the infant's two-month birthday, and the fourth payment on the infant's three-month birthdays.
Find a Location
Who is running the clinical trial?
University of PennsylvaniaOTHER
2,002 Previous Clinical Trials
42,880,975 Total Patients Enrolled
22 Trials studying Premature Birth
12,058 Patients Enrolled for Premature Birth
Children's Hospital of PhiladelphiaLead Sponsor
708 Previous Clinical Trials
8,580,983 Total Patients Enrolled
12 Trials studying Premature Birth
4,175 Patients Enrolled for Premature Birth
Andrea Duncan, MDPrincipal InvestigatorChildren's Hospital of Philadelphia/University of Pennsylvania
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: High-Value Cash Transfer
- Group 2: Low-Value Cash Transfer
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there still an opportunity to join this research endeavor?
"According to official records on clinicaltrials.gov, this study is not accepting new patients currently. The trial was initially published on July 26th 2023 and had its latest update by June 26th 2023. At the moment, 253 other trials are actively recruiting volunteers for medical research."
Answered by AI
Share this study with friends
Copy Link
Messenger